Delivery Order SPE2DB20D3103-SPE2DB24FP9Z1

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of TREMFYA 100 MG/ML INJECTORML. The contract has a ceiling value of $12,932.31 and runs through February 24, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML INJECTOR, a specialty medication, with a firm fixed price ceiling value of $27,514.66 and a completion date of August 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML syringes, a specialty medication. The delivery order has a firm fixed price ceiling value of $18,120.33 and is scheduled for completion by March 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,090.69, is for the supply of TREMFYA 100 MG/ML INJECTORML, a medication, with a period of performance through May 2, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, with a ceiling value of $10,084.76 and a performance period ending on May 15, 2025. The contract is a firm fixed-price delivery order, indicating it was competitively awarded without any set-aside designation....
This is a $8,493.51 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of TREMFYA 100 MG/ML INJECTORML. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,784.98, is for the supply of TREMFYA 100 MG/ML SYRINGE medication. It is a firm fixed-price contract with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,735.26, is for the delivery of the medication TREMFYA 100 MG/ML INJECTORML. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TREMFYA 100 MG/ML ONE-PRESSML, a medical product, with a ceiling value of $15,405.74 and a performance period ending on June 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,297.90 firm fixed-price contract is for the delivery of TREMFYA 100 MG/ML syringes, with a completion date of September 16, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP9Z1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TREMFYA 100 MG/ML injector medication. The contract has a ceiling value of $16,500.90 and a period of performance through August 23, 2024. It is a firm-fixed-price contract, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:13 AM